F&P Healthcare: don’t mention the tariffs!

F&P Healthcare: don’t mention the tariffs!
F&P Healthcare CEO Lewis Gradon - playing the long game (Image: Supplied)
Pattrick Smellie
Fisher & Paykel Healthcare senior leaders were keeping their heads down on the potential impact of US tariffs on its business during an investors’ call on the company’s stellar half-year results.“We really don't want to be drawn into any speculation on that whatsoever,” said managing director and chief executive, Lewis Gradon.However, there were hints that its newly opened Chinese plant is unlikely to be sending products to the US, since the Guangzhou facility is primarily expected to service the Chinese mar...

More Markets

TradeWindow raises run rate, narrows loss
Markets

TradeWindow raises run rate, narrows loss

Company remains on track for monthly breakeven in the first half of next year.

Tower reports $74m profit under tranquil skies
Markets

Tower reports $74m profit under tranquil skies

Tower customers are shunning cars popular with thieves.

Record half for F&P Healthcare
Markets

Record half for F&P Healthcare

A strong result boosts dividend, suspends dividend reinvestment scheme.